Clinical Trials Browser

Alzheimer Disease × Melphalan × Plasma cell × Clear all

NCT01083316 2020-09-25

Bortezomib and Dexamethasone Followed by High-Dose Melphalan and Stem Cell Transplantation for Primary (AL) Amyloidosis

Phase 2 Completed

35 enrolled 9 charts

Immunoglobulin Light-chain Amyloidosis, Alzheimer Disease, Amyloidosis